Clinical Trials Browser

Thymoma × Drug Therapy × 90 days × Clear all

NCT06402708 2026-04-27

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Phase 3 Recruiting

Thymoma